Nonfunctioning endocrine pancreatic tumor examined with 18F-FDG PET/CT
A 71-year-old woman with type 2 diabetes mellitus complained of generalized fatigue. A 36-mm tumor in the pancreatic tail was detected with ultrasonography. The tumor was found to have marked hypervascularity with contrast-enhanced computed tomography (CT) and magnetic resonance. Combined 18 F-fluor...
Gespeichert in:
Veröffentlicht in: | Annals of nuclear medicine 2008-02, Vol.22 (2), p.133-137 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | A 71-year-old woman with type 2 diabetes mellitus complained of generalized fatigue. A 36-mm tumor in the pancreatic tail was detected with ultrasonography. The tumor was found to have marked hypervascularity with contrast-enhanced computed tomography (CT) and magnetic resonance. Combined
18
F-fluorodeoxyglucose positron emission tomography and CT (
18
F-FDG PET/CT) showed
18
F-FDG by the tumor with a maximal standardized uptake value of 2.98 at 50 min and 3.29 at 100 min following injection of
18
F-FDG.
18
F-FDG PET/CT suggested no extrapancreatic spread of the tumor. The patient had no pancreatic hormone-associated symptoms. Distal pancreatectomy was performed, and a well-differentiated endocrine tumor was diagnosed. The resected specimen showed neither infiltration of adjacent structures nor metastasis to regional lymph nodes. The present case suggests that
18
F-FDG PET/CT is a reliable modality for staging endocrine pancreatic tumors. |
---|---|
ISSN: | 0914-7187 1864-6433 |
DOI: | 10.1007/s12149-007-0085-0 |